Cargando…
Gene mutations and actionable genetic lesions in mantle cell lymphoma
Mutations and epigenetic alterations are key events in transforming normal cells to cancer cells. Mantle cell lymphoma (MCL), a non-Hodgkin's lymphoma of the B-cell, is an aggressive malignancy with poor prognosis especially for those patients who are resistant to the frontline drugs. There is...
Autores principales: | Ahmed, Makhdum, Zhang, Leo, Nomie, Krystle, Lam, Laura, Wang, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295458/ https://www.ncbi.nlm.nih.gov/pubmed/27449094 http://dx.doi.org/10.18632/oncotarget.10716 |
Ejemplares similares
-
The B cell receptor signaling pathway in mantle cell lymphoma
por: Merolle, Maria I., et al.
Publicado: (2018) -
Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017) -
NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
por: Balaji, Swathi, et al.
Publicado: (2018) -
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
por: Huang, Shengjian, et al.
Publicado: (2018) -
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
por: Ye, Haige, et al.
Publicado: (2018)